Vermilion Energy: A Solid Q3 2025 And An Appealing Valuation Using Conservative Energy Price Assumptions
Vermilion Energy is rated a strong buy due to its extremely cheap valuation and attractive free cash flow yield using low-cycle energy price assumptions. VET's recent M&A activity has shifted its asset mix, increasing Canadian natural gas exposure and production to 120,000 boe/d. Despite poor stock performance and increased leverage, VET offers a 13% free cash flow yield at current energy prices, with significant upside if energy prices rebound.
Vermilion Energy: Positioning For The Next Era Of Natural Gas While Trading At A Deep Discount
Vermilion Energy is rated a Strong Buy, trading at a significant discount to book and fair value with major production growth amid ongoing portfolio rebalancing. VET is transitioning to focus on long-life, high-quality natural gas assets in Canada and Europe, with a 40% production increase expected to fully materialize by 2026, already visible now. The company targets a balanced approach: debt reduction, disciplined CAPEX, a 4.9% dividend yield, and share buybacks while maintaining financial health and production growth.
Vermilion Energy Inc. (VET) Q2 2025 Earnings Call Transcript
Vermilion Energy Inc. (NYSE:VET ) Q2 2025 Earnings Conference Call August 8, 2025 11:00 AM ET Company Participants Anthony Hatcher - President, CEO & Director Kyle Preston - Vice President of Investor Relations Lars William Glemser - VP & CFO Randy McQuade - Corporate Participant Conference Call Participants Chris Worley - Unidentified Company Greg M. Pardy - RBC Capital Markets, Research Division Menno Hulshof - TD Cowen, Research Division Operator Good morning, ladies and gentlemen.
Vermilion Energy (VET) Reports Q2 Loss, Misses Revenue Estimates
Vermilion Energy (VET) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.38 per share a year ago.
Wall Street Analysts Think Vermilion (VET) Could Surge 25.79%: Read This Before Placing a Bet
The mean of analysts' price targets for Vermilion (VET) points to a 25.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Fast-paced Momentum Stock Vermilion (VET) Is Still Trading at a Bargain
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Vermilion (VET) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Vermilion Energy (VET) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Vermilion (VET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Investors Undervaluing Vermilion Energy (VET) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here is Why Growth Investors Should Buy Vermilion (VET) Now
Vermilion (VET) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Should Value Investors Buy Vermilion Energy (VET) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Looking for a Growth Stock? 3 Reasons Why Vermilion (VET) is a Solid Choice
Vermilion (VET) possesses solid growth attributes, which could help it handily outperform the market.
Wall Street Analysts See a 29.73% Upside in Vermilion (VET): Can the Stock Really Move This High?
The mean of analysts' price targets for Vermilion (VET) points to a 29.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
